Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-04-18

Clinical Trial Update: International Registry on the Quality of Life of Patients With Grass-pollen-induced Allergic Rhinitis

View source ↗

Summary

A multinational registry study on quality of life in grass-pollen-induced allergic rhinitis sponsored by Stallergenes Greer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Stallergenes Greer | Conditions: Allergic Rhinitis Due to Grass Pollens | Status: TERMINATED